These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3122700)

  • 41. Long-term efficacy and safety of bupropion.
    Othmer E; Othmer SC; Stern WC; Van Wyck Fleet J
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):153-6. PubMed ID: 6406448
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine.
    Nathan RS; Perel JM; Pollock BG; Kupfer DJ
    J Clin Psychiatry; 1990 Sep; 51(9):367-72. PubMed ID: 2120201
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of desipramine and fluvoxamine treatment on the prolactin response to tryptophan. Serotonergic function and the mechanism of antidepressant action.
    Price LH; Charney DS; Delgado PL; Anderson GM; Heninger GR
    Arch Gen Psychiatry; 1989 Jul; 46(7):625-31. PubMed ID: 2500111
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The new generation antidepressants: promising innovations or disappointments?
    Ostrow D
    J Clin Psychiatry; 1985 Oct; 46(10 Pt 2):25-31. PubMed ID: 2995327
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels.
    Sales AJ; Crestani CC; Guimarães FS; Joca SRL
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():255-261. PubMed ID: 29885468
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical efficacy of the new antidepressant bupropion (Wellbutrin) [proceedings].
    Halaris AE; Stern W; Harto-Truax N
    Psychopharmacol Bull; 1981 Jan; 17(1):140-2. PubMed ID: 6785817
    [No Abstract]   [Full Text] [Related]  

  • 47. The new generation of antidepressants.
    Feighner JP
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):49-55. PubMed ID: 6222037
    [No Abstract]   [Full Text] [Related]  

  • 48. Tranylcypromine in mind (Part II): Review of clinical pharmacology and meta-analysis of controlled studies in depression.
    Ricken R; Ulrich S; Schlattmann P; Adli M
    Eur Neuropsychopharmacol; 2017 Aug; 27(8):714-731. PubMed ID: 28579071
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiovascular effects of bupropion in depressed patients with heart disease.
    Roose SP; Dalack GW; Glassman AH; Woodring S; Walsh BT; Giardina EG
    Am J Psychiatry; 1991 Apr; 148(4):512-6. PubMed ID: 1900980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of the inhibitory effect of some antidepressant drugs on the outward transport of norepinephrine in the ischemic myocardium.
    Carlsson L; Abrahamsson T
    J Pharmacol Exp Ther; 1988 Nov; 247(2):715-20. PubMed ID: 3263495
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Presynaptic adrenergic receptor sensitivity in depression. The effect of long-term desipramine treatment.
    Charney DS; Heninger GR; Sternberg DE; Redmond DE; Leckman JF; Maas JW; Roth RH
    Arch Gen Psychiatry; 1981 Dec; 38(12):1334-40. PubMed ID: 6274268
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Duloxetine increases serotonin and norepinephrine availability in healthy subjects: a double-blind, controlled study.
    Chalon SA; Granier LA; Vandenhende FR; Bieck PR; Bymaster FP; Joliat MJ; Hirth C; Potter WZ
    Neuropsychopharmacology; 2003 Sep; 28(9):1685-93. PubMed ID: 12784100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Desmethylimipramine treatment increases melatonin production in humans.
    Sack RL; Lewy AJ
    Biol Psychiatry; 1986 Apr; 21(4):406-10. PubMed ID: 3006804
    [No Abstract]   [Full Text] [Related]  

  • 54. Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments.
    Karoum F; Korpi ER; Linnoila M; Chuang LW; Wyatt RJ
    Eur J Pharmacol; 1984 Apr; 100(2):137-44. PubMed ID: 6234178
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of bupropion in tricyclic-resistant or intolerant patients.
    Stern WC; Harto-Truax N; Bauer N
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):148-52. PubMed ID: 6406447
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Noradrenaline uptake inhibition increases melatonin secretion, a measure of noradrenergic neurotransmission, in depressed patients.
    Palazidou E; Papadopoulos A; Ratcliff H; Dawling S; Checkley SA
    Psychol Med; 1992 May; 22(2):309-15. PubMed ID: 1319597
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Apparent turnover of norepinephrine in the intact rat brain estimated from its rate of appearance in the cerebroventricular compartment.
    Levitt M; Kowalik S; Barkai AI
    J Neurosci Res; 1983; 10(1):93-9. PubMed ID: 6887283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of dopamine and norepinephrine in depression and antidepressant treatment.
    Nutt DJ
    J Clin Psychiatry; 2006; 67 Suppl 6():3-8. PubMed ID: 16848670
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bupropion: new therapy for depression.
    Feinberg M
    Am Fam Physician; 1990 Jun; 41(6):1787-90. PubMed ID: 2112333
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biphasic change in BDNF gene expression following antidepressant drug treatment explained by differential transcript regulation.
    Khundakar AA; Zetterström TSC
    Brain Res; 2006 Aug; 1106(1):12-20. PubMed ID: 16842762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.